SIGN2024EN

SIGN 170: Optimising glycaemic control in people with type 1 diabetes

Zusammenfassung

Optimising glycaemic control in people with type 1 diabetes Quick reference guide March 2024 SI GN170 This Quick Reference Guide provides a summary of the main recommendations in SIGN 170 Optimising glycaemic control in people with type 1 diabetes. Recommendations R have been adapted from published evidence-based clinical guidance. Details of the publications from which these recommendations have been sourced can be found in the toolkit, available on the SIGN website: www.sign.ac.uk 2 En

Kerninformationen

R Referrals for treatment of depression or anxiety should be made to mental health services with experience using cognitive behavioural therapy or other evidence-based treatment approaches in conjunction with collaborative care with the person’s diabetes treatment team. 3 R To minimise inequalit...
R Offer real-time continuous glucose monitoring to all children and young people with type 1 diabetes, alongside education to support children and young people and their families and carers to use it. R The continuation of CGM and/or continuous subcutaneous insulin infusion should be considered i...
Originaldokument ansehen

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen

Verwandte Leitlinien